Table 3.

Additional cytogenetic abnormalities in patients with previously untreated CBF AML

UPN	Sex	Secondary chromosome abnormality(s)
Patients with t(8;21)
1	Female	‒X
5	Female	‒X
48	Female	‒X
58	Female	‒X
6	Male	‒Y
7	Male	‒Y
10	Male	‒Y
23	Male	‒Y
4	Male	del(9)(q13q22)
12	Female	del(9)(q13q22)
47	Male	del(9)(q31q33)
13	Female	‒X,del(9)(q13q22)
16	Male	‒Y,del(9)(q12q22)
45	Male	‒Y,del(9)(q13q22)
34	Male	+4
43	Female	add(5)(q33)
27	Male	+8/del(12)(p12)
11	Female	Tetraploid clone with t(8;21)x2
Patients with inv(16) or t(16;16)
20	Male	+8
46	Female	+8
8	Female	+8/add(17)(q23)
14	Male	+6,+8,+19,+20,+21,+22
37	Female	t(11;20)(p15;q11.2)/+8,t(11;20)(p15;q11.2)
52	Male	+21/+6,+8,+13,+21/+13,t(13;16)(q14;q24),+20,+21/+13,+21
56	Female	del(7)(q32q36)/+8,+14,+14,+21/+22
42	Male	+6
28	Female	+9
22	Male	+22
33	Female	del(16)(q22q22)/del(16)(q22q22),+22
36	Female	+9,+14,+22
30	Male	del(5)(q15q34)
29	Female	der(1)inv(1)(p13.3q11)del(1)(q41q43),t(4;6)(q34;p12),add(7)(q34), ‒10,+r,+mar